Research study uses clinic records to compare effect of face-to-face and telepsychiatry medication assisted treatment (MAT) programs for opioid use disorder
Treatment Outcome Comparison between face-to-face and Telepsychiatry MAT Buprenorphine for Opioid Dependence: A 2-Year Retrospective Data Analysis
School, Department, or Center
School of Medicine, Department of Behavioral Medicine & Psychiatry
Wanhong Zheng, MD, MSc, MA Carl Sullivan, MD
This is a retrospective study where clinic records will be reviewed to compare the effect of face-to-face and telepsychiatry medication-assisted treatment (MAT) programs for opioid use disorder on three outcomes: (1) retention rate in weekly and biweekly groups; (2) average time to get to first 90 consecutive days sobriety in biweekly and monthly groups; (3) Relapse rates in weekly and biweekly groups. We will identify all COAT clinic patients under one psychiatrist who provided medication management through both telepsychiatry and face-to-face method during the same study period: from 01/01/2013 to 12/31/2014. Patients included in the study received MAT services in weekly, biweekly, and monthly groups at CRC and telepsychiatry sites from the same psychiatrist during the study period. Even if they attended group therapies at different locations, the structure and goals of therapy are identical, and the treatment requirements including attendance follow same agreement and policy. Treatment retention and relapse rates between the two groups will be compared.
Monongalia, Mercer, and McDowell Counties and surrounding areas« Back to Research Initiatives